Creator: Dr. Tran Le, MD, DABOM
Published: 2026-06-22T14:07:17+00:00

GLP-1 medications get most of the attention right now, but they aren't the only effective tools, and they aren't right for everyone. For some patients, an older, well-understood oral medication is the smarter starting point. This is a clinical decision, not a vending-machine choice, which is why our program is physician-led by Dr. Tran Le, MD, DABOM, board-certified in Obesity Medicine, Addiction Medicine, and Occupational & Environmental Medicine.

Phentermine and oral weight-loss options: when a non-GLP-1 fits

The honest answer is that the best weight-loss medication is the one that matches your biology, your other health conditions, your budget, and what you can stick with. Major obesity guidelines say the same thing in clinical language: the selection of the medication should be based on the clinical profile and needs of the patient, including comorbidities, patients' preferences, costs, and access to the therapy. The American Association of Clinical Endocrinology likewise recommends individualizing the choice of pharmacotherapy based on obesity-related conditions, comorbidities, and potential adverse events.

In our practice, an oral, non-GLP-1 option is often the right fit when a patient wants to avoid injections, when cost or access is a barrier, when a GLP-1 isn't tolerated or appropriate, or when the goal is a focused, shorter-term jump-start alongside diet and activity changes.

How phentermine actually works

Phentermine is one of the oldest prescription weight-loss medications still in use. It was approved in 1959 by the FDA as an adjunct to diet. Mechanistically, it's an appetite suppressant: its action appears to be related to stimulation of the hypothalamus to release norepinephrine, resulting in reduced appetite. In plain terms, it turns down hunger signals so a reduced-calorie plan feels more doable.

A couple of practical points we discuss with every patient. First, phentermine is FDA approved for short-term use (up to 12 weeks), and it works best with the basics in place: carefully following a reduced-calorie diet plan and regular exercise. Second, it's a stimulant, so timing matters: to avoid trouble sleeping, the last dose of the day is usually taken about 4 to 6 hours before bedtime.

Other oral options beyond phentermine

Phentermine isn't the only non-injectable tool. Two others come up often:

Phentermine/topiramate

Combining phentermine with topiramate targets appetite through more than one pathway. These mechanisms include reducing appetite through inhibition of norepinephrine reuptake (phentermine) and reduction of hypothalamic glutamate neurotransmission (topiramate), enhancing satiety, and increasing energy expenditure. This combination was approved by the FDA in 2012 for adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition. In meta-analysis, it has performed strongly among oral agents: phentermine/topiramate ER currently appears to be the most effective available oral obesity pharmacotherapy, although longer-term data are required.

Naltrexone/bupropion

This combination works on appetite and reward rather than as a stimulant. Its proposed mechanism involves complementary stimulation of central melanocortin pathways, resulting in increased energy expenditure and reduced appetite, with effects on the hypothalamus (the appetite regulatory center) and the mesolimbic dopamine circuit (the reward system). It was approved by the FDA in September 2014 to treat obesity. This one can be a thoughtful fit for patients whose eating is driven by cravings and reward, and it's an area where Dr. Le's Addiction Medicine background is genuinely useful.

You can read more about these on our oral medications page, and see how the program runs on how it works.

When a GLP-1 is usually the better choice

Non-GLP-1 doesn't mean "always first." For many patients, especially those with type 2 diabetes, guideline bodies lean toward incretin therapy (treatments that mimic gut hormones). For people with diabetes and overweight or obesity, the ADA recommends as preferred pharmacotherapy a GLP-1 receptor agonist or a dual GLP-1/GIP receptor agonist with substantial weight-loss efficacy. We offer GLP-1 options too: all-inclusive compounded semaglutide and tirzepatide, plus an à la carte plan for brand-name GLP-1s like Wegovy, Ozempic, Zepbound, and Mounjaro. (Note that compounded medications are not FDA-approved.) See the medications overview and pricing for details.

Who should be cautious with phentermine

This is exactly why a physician, not an algorithm, should make the call. Because phentermine raises sympathetic tone, it isn't right for everyone. Cardiovascular contraindications for the use of phentermine include a history of coronary artery disease, stroke, arrhythmias, congestive heart failure, and uncontrolled hypertension. More broadly, phentermine is contraindicated in patients with advanced arteriosclerosis, hyperthyroidism, moderate to severe hypertension, symptomatic cardiovascular disease, agitated states, a history of drug abuse, or glaucoma, and also within 14 days of taking monoamine oxidase inhibitors (MAOIs). There are even rare reports linking it to coronary issues. A Mayo Clinic Proceedings series noted that phentermine may have vasospastic properties that are important to consider when prescribing.

None of this means phentermine is dangerous when prescribed appropriately. It means the evaluation matters. We review your cardiac history, blood pressure, medications, and goals before prescribing anything. This article is educational and isn't a substitute for that personal evaluation.

Frequently asked questions

Is phentermine less effective than a GLP-1?

They work differently and the research isn't a simple head-to-head ranking. The right comparison isn't "which is strongest on paper" but which fits your health profile, tolerance, and goals. For patients with diabetes, guidelines often favor a GLP-1; for others, an oral agent may be a sensible, lower-cost starting point. The physician decides with you.

How long can I take phentermine?

Phentermine is FDA approved for short-term use (up to 12 weeks). The phentermine/topiramate combination, by contrast, was approved by the FDA in 2012 for long-term weight management. Your prescriber will set a plan based on your response and health.

Do oral medications still require diet and exercise?

Yes. Across the board, these medications are intended to be used alongside lifestyle changes. They make the work more achievable, not optional.

Talk to a physician about the right fit

If you're weighing phentermine and oral weight-loss options against a GLP-1, the best next step is a real clinical conversation. Our Texas- and Utah-based program is physician-led by Dr. Le, and we'll match the plan to you, including a Medicare GLP-1 bridge option where it applies. Start your consultation here.

Phentermine & Oral Weight-Loss Options: When a Non-GLP-1 Fits